Tumor necrosis and infiltrating macrophages predict survival after curative resection for cholangiocarcinoma

Background. Tumor necrosis as well as tumor-associated macrophages (TAMs) in the tumor invasive front (TIF) have been suggested to have a prognostic value in selected solid tumors, inclusive hilar cholangiocarcinoma. However, little is known regarding their influence on tumor progression and prognos...

Full description

Bibliographic Details
Main Authors: Georgi Atanasov, Corinna Dietel, Linda Feldbrügge, Christian Benzing, Felix Krenzien, Andreas Brandl, Elli Mann, Julianna Paulina Englisch, Katrin Schierle, Simon C. Robson, Katrin Splith, Mehmet Haluk Morgul, Anja Reutzel-Selke, Sven Jonas, Andreas Pascher, Marcus Bahra, Johann Pratschke, Moritz Schmelzle
Format: Article
Language:English
Published: Taylor & Francis Group 2017-08-01
Series:OncoImmunology
Subjects:
Online Access:http://dx.doi.org/10.1080/2162402X.2017.1331806
id doaj-637ca2c8a33b4b1cbf938c15186cbf81
record_format Article
spelling doaj-637ca2c8a33b4b1cbf938c15186cbf812020-11-25T03:33:05ZengTaylor & Francis GroupOncoImmunology2162-402X2017-08-016810.1080/2162402X.2017.13318061331806Tumor necrosis and infiltrating macrophages predict survival after curative resection for cholangiocarcinomaGeorgi Atanasov0Corinna Dietel1Linda Feldbrügge2Christian Benzing3Felix Krenzien4Andreas Brandl5Elli Mann6Julianna Paulina Englisch7Katrin Schierle8Simon C. Robson9Katrin Splith10Mehmet Haluk Morgul11Anja Reutzel-Selke12Sven Jonas13Andreas Pascher14Marcus Bahra15Johann Pratschke16Moritz Schmelzle17Campus Virchow-Klinikum and Charité Campus Mitte, Charité – Universitätsmedizin BerlinUniversity Hospital LeipzigCampus Virchow-Klinikum and Charité Campus Mitte, Charité – Universitätsmedizin BerlinCampus Virchow-Klinikum and Charité Campus Mitte, Charité – Universitätsmedizin BerlinCampus Virchow-Klinikum and Charité Campus Mitte, Charité – Universitätsmedizin BerlinCampus Virchow-Klinikum and Charité Campus Mitte, Charité – Universitätsmedizin BerlinCampus Virchow-Klinikum and Charité Campus Mitte, Charité – Universitätsmedizin BerlinCampus Virchow-Klinikum and Charité Campus Mitte, Charité – Universitätsmedizin BerlinInstitute of Pathology, University Hospital LeipzigThe Transplant Institute and Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard UniversityCampus Virchow-Klinikum and Charité Campus Mitte, Charité – Universitätsmedizin BerlinCampus Virchow-Klinikum and Charité Campus Mitte, Charité – Universitätsmedizin BerlinCampus Virchow-Klinikum and Charité Campus Mitte, Charité – Universitätsmedizin BerlinDepartment of Hepato-Pancreato-Biliary SurgeryCampus Virchow-Klinikum and Charité Campus Mitte, Charité – Universitätsmedizin BerlinCampus Virchow-Klinikum and Charité Campus Mitte, Charité – Universitätsmedizin BerlinCampus Virchow-Klinikum and Charité Campus Mitte, Charité – Universitätsmedizin BerlinCampus Virchow-Klinikum and Charité Campus Mitte, Charité – Universitätsmedizin BerlinBackground. Tumor necrosis as well as tumor-associated macrophages (TAMs) in the tumor invasive front (TIF) have been suggested to have a prognostic value in selected solid tumors, inclusive hilar cholangiocarcinoma. However, little is known regarding their influence on tumor progression and prognosis in intrahepatic cholangiocarcinoma (iCC). Methods. We analyzed surgically resected tumor specimens of human iCC (n = 88) for distribution and localization of TAMs, as defined by expression of CD68, formation of necrosis and extent of peritumoral fibrosis. Abundance of TAMs, tumor necrosis and grade of fibrosis were assessed immunohistochemically and histologically and correlated with clinicopathological characteristics, tumor recurrence and patients' survival. Statistical analysis was performed using SPSS software. Results. Patients with tumors characterized by low levels of TAMs in TIF or necrosis showed a significantly decreased 1-, 3- and 5-y recurrence-free survival and a significantly decreased overall survival, when compared with patients with tumors showing high levels of TAMs in TIF or no necrosis. Patients with high density of TAMs in TIF showed significantly lower incidence of tumor recurrence, as well (p < 0.05). Absence of tumor necrosis and TAMs in TIF were confirmed as independent prognostic variables in the multivariate survival analysis (all p < 0.05). Conclusions. High levels of TAMs in TIF or absence of histologic tumor necrosis are associated with a significantly improved recurrence-free and overall survival of patients with iCC. These results suggest TAMs and necrosis as valuable prognostic markers in routine histopathologic evaluation, and might indicate more individualized therapeutic strategies.http://dx.doi.org/10.1080/2162402X.2017.1331806intrahepatic cholangiocarcinomatumor associated macrophagestamscd68tumor necrosisfibrosisprognosispatient outcome
collection DOAJ
language English
format Article
sources DOAJ
author Georgi Atanasov
Corinna Dietel
Linda Feldbrügge
Christian Benzing
Felix Krenzien
Andreas Brandl
Elli Mann
Julianna Paulina Englisch
Katrin Schierle
Simon C. Robson
Katrin Splith
Mehmet Haluk Morgul
Anja Reutzel-Selke
Sven Jonas
Andreas Pascher
Marcus Bahra
Johann Pratschke
Moritz Schmelzle
spellingShingle Georgi Atanasov
Corinna Dietel
Linda Feldbrügge
Christian Benzing
Felix Krenzien
Andreas Brandl
Elli Mann
Julianna Paulina Englisch
Katrin Schierle
Simon C. Robson
Katrin Splith
Mehmet Haluk Morgul
Anja Reutzel-Selke
Sven Jonas
Andreas Pascher
Marcus Bahra
Johann Pratschke
Moritz Schmelzle
Tumor necrosis and infiltrating macrophages predict survival after curative resection for cholangiocarcinoma
OncoImmunology
intrahepatic cholangiocarcinoma
tumor associated macrophages
tams
cd68
tumor necrosis
fibrosis
prognosis
patient outcome
author_facet Georgi Atanasov
Corinna Dietel
Linda Feldbrügge
Christian Benzing
Felix Krenzien
Andreas Brandl
Elli Mann
Julianna Paulina Englisch
Katrin Schierle
Simon C. Robson
Katrin Splith
Mehmet Haluk Morgul
Anja Reutzel-Selke
Sven Jonas
Andreas Pascher
Marcus Bahra
Johann Pratschke
Moritz Schmelzle
author_sort Georgi Atanasov
title Tumor necrosis and infiltrating macrophages predict survival after curative resection for cholangiocarcinoma
title_short Tumor necrosis and infiltrating macrophages predict survival after curative resection for cholangiocarcinoma
title_full Tumor necrosis and infiltrating macrophages predict survival after curative resection for cholangiocarcinoma
title_fullStr Tumor necrosis and infiltrating macrophages predict survival after curative resection for cholangiocarcinoma
title_full_unstemmed Tumor necrosis and infiltrating macrophages predict survival after curative resection for cholangiocarcinoma
title_sort tumor necrosis and infiltrating macrophages predict survival after curative resection for cholangiocarcinoma
publisher Taylor & Francis Group
series OncoImmunology
issn 2162-402X
publishDate 2017-08-01
description Background. Tumor necrosis as well as tumor-associated macrophages (TAMs) in the tumor invasive front (TIF) have been suggested to have a prognostic value in selected solid tumors, inclusive hilar cholangiocarcinoma. However, little is known regarding their influence on tumor progression and prognosis in intrahepatic cholangiocarcinoma (iCC). Methods. We analyzed surgically resected tumor specimens of human iCC (n = 88) for distribution and localization of TAMs, as defined by expression of CD68, formation of necrosis and extent of peritumoral fibrosis. Abundance of TAMs, tumor necrosis and grade of fibrosis were assessed immunohistochemically and histologically and correlated with clinicopathological characteristics, tumor recurrence and patients' survival. Statistical analysis was performed using SPSS software. Results. Patients with tumors characterized by low levels of TAMs in TIF or necrosis showed a significantly decreased 1-, 3- and 5-y recurrence-free survival and a significantly decreased overall survival, when compared with patients with tumors showing high levels of TAMs in TIF or no necrosis. Patients with high density of TAMs in TIF showed significantly lower incidence of tumor recurrence, as well (p < 0.05). Absence of tumor necrosis and TAMs in TIF were confirmed as independent prognostic variables in the multivariate survival analysis (all p < 0.05). Conclusions. High levels of TAMs in TIF or absence of histologic tumor necrosis are associated with a significantly improved recurrence-free and overall survival of patients with iCC. These results suggest TAMs and necrosis as valuable prognostic markers in routine histopathologic evaluation, and might indicate more individualized therapeutic strategies.
topic intrahepatic cholangiocarcinoma
tumor associated macrophages
tams
cd68
tumor necrosis
fibrosis
prognosis
patient outcome
url http://dx.doi.org/10.1080/2162402X.2017.1331806
work_keys_str_mv AT georgiatanasov tumornecrosisandinfiltratingmacrophagespredictsurvivalaftercurativeresectionforcholangiocarcinoma
AT corinnadietel tumornecrosisandinfiltratingmacrophagespredictsurvivalaftercurativeresectionforcholangiocarcinoma
AT lindafeldbrugge tumornecrosisandinfiltratingmacrophagespredictsurvivalaftercurativeresectionforcholangiocarcinoma
AT christianbenzing tumornecrosisandinfiltratingmacrophagespredictsurvivalaftercurativeresectionforcholangiocarcinoma
AT felixkrenzien tumornecrosisandinfiltratingmacrophagespredictsurvivalaftercurativeresectionforcholangiocarcinoma
AT andreasbrandl tumornecrosisandinfiltratingmacrophagespredictsurvivalaftercurativeresectionforcholangiocarcinoma
AT ellimann tumornecrosisandinfiltratingmacrophagespredictsurvivalaftercurativeresectionforcholangiocarcinoma
AT juliannapaulinaenglisch tumornecrosisandinfiltratingmacrophagespredictsurvivalaftercurativeresectionforcholangiocarcinoma
AT katrinschierle tumornecrosisandinfiltratingmacrophagespredictsurvivalaftercurativeresectionforcholangiocarcinoma
AT simoncrobson tumornecrosisandinfiltratingmacrophagespredictsurvivalaftercurativeresectionforcholangiocarcinoma
AT katrinsplith tumornecrosisandinfiltratingmacrophagespredictsurvivalaftercurativeresectionforcholangiocarcinoma
AT mehmethalukmorgul tumornecrosisandinfiltratingmacrophagespredictsurvivalaftercurativeresectionforcholangiocarcinoma
AT anjareutzelselke tumornecrosisandinfiltratingmacrophagespredictsurvivalaftercurativeresectionforcholangiocarcinoma
AT svenjonas tumornecrosisandinfiltratingmacrophagespredictsurvivalaftercurativeresectionforcholangiocarcinoma
AT andreaspascher tumornecrosisandinfiltratingmacrophagespredictsurvivalaftercurativeresectionforcholangiocarcinoma
AT marcusbahra tumornecrosisandinfiltratingmacrophagespredictsurvivalaftercurativeresectionforcholangiocarcinoma
AT johannpratschke tumornecrosisandinfiltratingmacrophagespredictsurvivalaftercurativeresectionforcholangiocarcinoma
AT moritzschmelzle tumornecrosisandinfiltratingmacrophagespredictsurvivalaftercurativeresectionforcholangiocarcinoma
_version_ 1724564768367312896